secwatch.observer — SEC 8-K summary
======================================

Issuer:     Microbot Medical Inc. (MBOT)
CIK:        0000883975
Form:       8-K
Filed at:   2025-07-08T23:59:59+00:00
Accession:  0001641172-25-018098
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Microbot to present at inaugural SRS Endovascular Robotics session; FDA 510(k) decision expected this quarter
--------------------------------------------------------------------------------

- Participates in Society of Robotic Surgery annual meeting July 16-20 in Strasbourg, France.
- CEO Harel Gadot to present overview of endovascular robotics market at panel on July 19.
- Company strengthening sales & marketing infrastructure ahead of anticipated U.S. FDA 510(k) decision this quarter.
- Liberty system remains investigational; not yet approved for sale in the U.S.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883975/000164117225018098/0001641172-25-018098-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883975/000164117225018098/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-018098

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer